Literature DB >> 24388173

Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics.

Kevin G Chen1, Barbara S Mallon2, Ronald D G McKay3, Pamela G Robey4.   

Abstract

Human pluripotent stem cells (hPSCs) provide powerful resources for application in regenerative medicine and pharmaceutical development. In the past decade, various methods have been developed for large-scale hPSC culture that rely on combined use of multiple growth components, including media containing various growth factors, extracellular matrices, 3D environmental cues, and modes of multicellular association. In this Protocol Review, we dissect these growth components by comparing cell culture methods and identifying the benefits and pitfalls associated with each one. We further provide criteria, considerations, and suggestions to achieve optimal cell growth for hPSC expansion, differentiation, and use in future therapeutic applications.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24388173      PMCID: PMC3915741          DOI: 10.1016/j.stem.2013.12.005

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  105 in total

1.  Rapid expansion of human hematopoietic stem cells by automated control of inhibitory feedback signaling.

Authors:  Elizabeth Csaszar; Daniel C Kirouac; Mei Yu; WeiJia Wang; Wenlian Qiao; Michael P Cooke; Anthony E Boitano; Caryn Ito; Peter W Zandstra
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

2.  Self-formation of optic cups and storable stratified neural retina from human ESCs.

Authors:  Tokushige Nakano; Satoshi Ando; Nozomu Takata; Masako Kawada; Keiko Muguruma; Kiyotoshi Sekiguchi; Koichi Saito; Shigenobu Yonemura; Mototsugu Eiraku; Yoshiki Sasai
Journal:  Cell Stem Cell       Date:  2012-06-14       Impact factor: 24.633

3.  Surface-engineered substrates for improved human pluripotent stem cell culture under fully defined conditions.

Authors:  Krishanu Saha; Ying Mei; Colin M Reisterer; Neena Kenton Pyzocha; Jing Yang; Julien Muffat; Martyn C Davies; Morgan R Alexander; Robert Langer; Daniel G Anderson; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

4.  Establishing a dynamic process for the formation, propagation, and differentiation of human embryoid bodies.

Authors:  Galia Yirme; Michal Amit; Ilana Laevsky; Sivan Osenberg; Joseph Itskovitz-Eldor
Journal:  Stem Cells Dev       Date:  2008-12       Impact factor: 3.272

5.  Meeting report of the International Consortium of Stem Cell Networks' Workshop Towards Clinical Trials Using Stem Cells for Amyotrophic Lateral Sclerosis/Motor Neuron Disease.

Authors:  Maya R Chaddah; Brian G Dickie; Drew Lyall; Caroline J Marshall; J Ben Sykes; Lucie I Bruijn
Journal:  Amyotroph Lateral Scler       Date:  2011-08-03

6.  Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells.

Authors:  Guokai Chen; Zhonggang Hou; Daniel R Gulbranson; James A Thomson
Journal:  Cell Stem Cell       Date:  2010-08-06       Impact factor: 24.633

7.  Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells.

Authors:  Lei Xiao; Xuan Yuan; Saul J Sharkis
Journal:  Stem Cells       Date:  2006-02-02       Impact factor: 6.277

8.  Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products.

Authors:  Yan Li; Sandra Powell; Elisa Brunette; Jane Lebkowski; Ramkumar Mandalam
Journal:  Biotechnol Bioeng       Date:  2005-09-20       Impact factor: 4.530

Review 9.  Genetic and epigenetic variations in iPSCs: potential causes and implications for application.

Authors:  Gaoyang Liang; Yi Zhang
Journal:  Cell Stem Cell       Date:  2013-08-01       Impact factor: 24.633

10.  Microencapsulation technology: a powerful tool for integrating expansion and cryopreservation of human embryonic stem cells.

Authors:  Margarida Serra; Cláudia Correia; Rita Malpique; Catarina Brito; Janne Jensen; Petter Bjorquist; Manuel J T Carrondo; Paula M Alves
Journal:  PLoS One       Date:  2011-08-05       Impact factor: 3.240

View more
  110 in total

1.  Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells.

Authors:  Daniel Paull; Ana Sevilla; Hongyan Zhou; Aana Kim Hahn; Hesed Kim; Christopher Napolitano; Alexander Tsankov; Linshan Shang; Katie Krumholz; Premlatha Jagadeesan; Chris M Woodard; Bruce Sun; Thierry Vilboux; Matthew Zimmer; Eliana Forero; Dorota N Moroziewicz; Hector Martinez; May Christine V Malicdan; Keren A Weiss; Lauren B Vensand; Carmen R Dusenberry; Hannah Polus; Karla Therese L Sy; David J Kahler; William A Gahl; Susan L Solomon; Stephen Chang; Alexander Meissner; Kevin Eggan; Scott A Noggle
Journal:  Nat Methods       Date:  2015-08-03       Impact factor: 28.547

2.  Integration Free Derivation of Human Induced Pluripotent Stem Cells Using Laminin 521 Matrix.

Authors:  Elias Uhlin; Ana Marin Navarro; Harriet Rönnholm; Kelly Day; Malin Kele; Anna Falk
Journal:  J Vis Exp       Date:  2017-07-07       Impact factor: 1.355

Review 3.  Application of biomaterials to advance induced pluripotent stem cell research and therapy.

Authors:  Zhixiang Tong; Aniruddh Solanki; Allison Hamilos; Oren Levy; Kendall Wen; Xiaolei Yin; Jeffrey M Karp
Journal:  EMBO J       Date:  2015-03-12       Impact factor: 11.598

Review 4.  Stem Cell Spheroids and Ex Vivo Niche Modeling: Rationalization and Scaling-Up.

Authors:  Isotta Chimenti; Diana Massai; Umberto Morbiducci; Antonio Paolo Beltrami; Maurizio Pesce; Elisa Messina
Journal:  J Cardiovasc Transl Res       Date:  2017-03-13       Impact factor: 4.132

5.  Robust Expansion of Human Pluripotent Stem Cells: Integration of Bioprocess Design With Transcriptomic and Metabolomic Characterization.

Authors:  Marta M Silva; Ana F Rodrigues; Cláudia Correia; Marcos F Q Sousa; Catarina Brito; Ana S Coroadinha; Margarida Serra; Paula M Alves
Journal:  Stem Cells Transl Med       Date:  2015-05-15       Impact factor: 6.940

6.  Patient-derived induced pluripotent stem cells in cancer research and precision oncology.

Authors:  Eirini P Papapetrou
Journal:  Nat Med       Date:  2016-12-06       Impact factor: 53.440

7.  Comparison between the cultures of human induced pluripotent stem cells (hiPSCs) on feeder-and serum-free system (Matrigel matrix), MEF and HDF feeder cell lines.

Authors:  Payam Ghasemi-Dehkordi; Mehdi Allahbakhshian-Farsani; Narges Abdian; Amin Mirzaeian; Javad Saffari-Chaleshtori; Fatemeh Heybati; Gashtasb Mardani; Alireza Karimi-Taghanaki; Abbas Doosti; Mohammad-Saeid Jami; Marziyeh Abolhasani; Morteza Hashemzadeh-Chaleshtori
Journal:  J Cell Commun Signal       Date:  2015-03-29       Impact factor: 5.782

8.  bFGF and Activin A function to promote survival and proliferation of single iPS cells in conditioned half-exchange mTeSR1 medium.

Authors:  Xiaoling Guo; Ruiling Lian; Yonglong Guo; Qing Liu; Qingshan Ji; Jiansu Chen
Journal:  Hum Cell       Date:  2015-03-10       Impact factor: 4.174

9.  Synthetic alternatives to Matrigel.

Authors:  Elizabeth A Aisenbrey; William L Murphy
Journal:  Nat Rev Mater       Date:  2020-05-27       Impact factor: 66.308

Review 10.  Functional nanoarrays for investigating stem cell fate and function.

Authors:  Jin-Ho Lee; Jeffrey Luo; Hye Kyu Choi; Sy-Tsong Dean Chueng; Ki-Bum Lee; Jeong-Woo Choi
Journal:  Nanoscale       Date:  2020-02-24       Impact factor: 7.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.